Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of PTK2B mRNA | affects expression | 21346803
|
C436284 |
2-cyclopentyl-5-(5-isoquinolylsulfonyl)-6-nitro-1H-benzo(D)imidazole |
2-cyclopentyl-5-(5-isoquinolylsulfonyl)-6-nitro-1H-benzo(D)imidazole inhibits the reaction [Acrylamide results in increased phosphorylation of PTK2B protein] | decreases reaction|increases phosphorylation | 11478917
|
C436284 |
2-cyclopentyl-5-(5-isoquinolylsulfonyl)-6-nitro-1H-benzo(D)imidazole |
2-cyclopentyl-5-(5-isoquinolylsulfonyl)-6-nitro-1H-benzo(D)imidazole inhibits the reaction [Colchicine results in increased phosphorylation of PTK2B protein] | decreases reaction|increases phosphorylation | 11478917
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of PTK2B mRNA | increases expression | 18648102
|
C108123 |
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine |
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Carbachol results in increased phosphorylation of and results in increased activity of PTK2B protein] | decreases reaction|increases activity|increases phosphorylation | 16877402
|
C003001 |
7-ketocholesterol |
7-ketocholesterol results in increased phosphorylation of and results in increased activity of PTK2B protein | increases activity|increases phosphorylation | 15955068
|
D020106 |
Acrylamide |
2-cyclopentyl-5-(5-isoquinolylsulfonyl)-6-nitro-1H-benzo(D)imidazole inhibits the reaction [Acrylamide results in increased phosphorylation of PTK2B protein] | decreases reaction|increases phosphorylation | 11478917
|
D020106 |
Acrylamide |
Acrylamide results in increased phosphorylation of PTK2B protein | increases phosphorylation | 11478917
|
C031143 |
AICA ribonucleotide |
AICA ribonucleotide results in increased phosphorylation of and results in increased activity of PTK2B protein | increases activity|increases phosphorylation | 11978788
|
C031143 |
AICA ribonucleotide |
PTK2B protein affects the reaction [AICA ribonucleotide results in increased activity of MAPK3 protein] | affects reaction|increases activity | 11978788
|
C031143 |
AICA ribonucleotide |
PTK2B protein affects the reaction [AICA ribonucleotide results in increased activity of PRKCZ protein] | affects reaction|increases activity | 11978788
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PTK2B mRNA | affects expression | 16483693
|
D000643 |
Ammonium Chloride |
Ammonium Chloride results in decreased expression of PTK2B protein modified form | decreases expression | 16483693
|
D000643 |
Ammonium Chloride |
Ammonium Chloride results in increased expression of PTK2B protein | increases expression | 16483693
|
D000643 |
Ammonium Chloride |
Ammonium Chloride results in increased expression of PTK2B protein modified form | increases expression | 16483693
|
D020001 |
1-Butanol |
1-Butanol inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of PTK2B protein] | decreases reaction|increases phosphorylation | 15705590
|
D020001 |
1-Butanol |
1-Butanol inhibits the reaction [Potassium Chloride results in increased phosphorylation of PTK2B protein] | decreases reaction|increases phosphorylation | 18004999
|
D002118 |
Calcium |
Calcium affects the reaction [(N)-methanocarba-2MeSADP results in increased phosphorylation of PTK2B protein] | affects reaction|increases phosphorylation | 16236484
|
D002118 |
Calcium |
Calcium affects the phosphorylation of and affects the activity of PTK2B protein | affects activity|affects phosphorylation | 16877402
|
D002217 |
Carbachol |
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Carbachol results in increased phosphorylation of and results in increased activity of PTK2B protein] | decreases reaction|increases activity|increases phosphorylation | 16877402
|
D002217 |
Carbachol |
Carbachol results in increased phosphorylation of and results in increased activity of PTK2B protein | increases activity|increases phosphorylation | 16877402
|
D002217 |
Carbachol |
Egtazic Acid inhibits the reaction [Carbachol results in increased phosphorylation of and results in increased activity of PTK2B protein] | decreases reaction|increases activity|increases phosphorylation | 16877402
|
D002217 |
Carbachol |
PTK2B protein affects the reaction [Carbachol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects reaction|increases activity|increases phosphorylation | 16877402
|
D002217 |
Carbachol |
PTK2B protein affects the reaction [Carbachol results in increased phosphorylation of and results in increased activity of MAPK3 protein] | affects reaction|increases activity|increases phosphorylation | 16877402
|
D002217 |
Carbachol |
SRC protein affects the reaction [Carbachol results in increased phosphorylation of and results in increased activity of PTK2B protein] | affects reaction|increases activity|increases phosphorylation | 16877402
|
D003078 |
Colchicine |
2-cyclopentyl-5-(5-isoquinolylsulfonyl)-6-nitro-1H-benzo(D)imidazole inhibits the reaction [Colchicine results in increased phosphorylation of PTK2B protein] | decreases reaction|increases phosphorylation | 11478917
|
D003078 |
Colchicine |
Colchicine results in increased phosphorylation of PTK2B protein | increases phosphorylation | 11478917
|
D003907 |
Dexamethasone |
Dexamethasone results in increased expression of PTK2B mRNA | increases expression | 12782123
|
D004317 |
Doxorubicin |
PTK2B protein inhibits the reaction [Doxorubicin results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16168102
|
D004533 |
Egtazic Acid |
Egtazic Acid inhibits the reaction [Carbachol results in increased phosphorylation of and results in increased activity of PTK2B protein] | decreases reaction|increases activity|increases phosphorylation | 16877402
|
D000431 |
Ethanol |
Ethanol results in increased phosphorylation of PTK2B protein | increases phosphorylation | 18182400
|
D000431 |
Ethanol |
sodium arsenite promotes the reaction [Ethanol results in increased phosphorylation of PTK2B protein] | increases phosphorylation|increases reaction | 18182400
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of PTK2B mRNA | decreases expression | 18035473
|
C053629 |
fluoroaluminum |
fluoroaluminum results in increased phosphorylation of PTK2B protein | increases phosphorylation | 11792571
|
C010176 |
halofuginone |
halofuginone results in increased expression of PTK2B mRNA | increases expression | 17180598
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of PTK2B mRNA | affects cotreatment|increases expression | 17183730
|
D006861 |
Hydrogen Peroxide |
1-Butanol inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of PTK2B protein] | decreases reaction|increases phosphorylation | 15705590
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide promotes the reaction [PTK2B protein binds to SRC protein] | affects binding|increases reaction | 15705590
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in increased phosphorylation of PTK2B protein | increases phosphorylation | 15705590
|
D006861 |
Hydrogen Peroxide |
PLD2 protein affects the reaction [Hydrogen Peroxide promotes the reaction [PTK2B protein binds to SRC protein]] | affects binding|affects reaction|increases reaction | 15705590
|
D006861 |
Hydrogen Peroxide |
PTK2B protein affects the reaction [Hydrogen Peroxide results in increased activity of and results in increased phosphorylation of AKT1 protein] | affects reaction|increases activity|increases phosphorylation | 15705590
|
D015759 |
Ionomycin |
Ionomycin results in increased phosphorylation of and results in increased activity of PTK2B protein | increases activity|increases phosphorylation | 16877402
|
C032881 |
lysophosphatidic acid |
lysophosphatidic acid results in increased phosphorylation of PTK2B protein | increases phosphorylation | 11792571
|
D008345 |
Manganese |
Manganese results in decreased expression of PTK2B mRNA | decreases expression | 17175027
|
C025340 |
manganese chloride |
manganese chloride results in decreased expression of PTK2B mRNA | decreases expression | 17175027
|
C511689 |
(N)-methanocarba-2MeSADP |
Calcium affects the reaction [(N)-methanocarba-2MeSADP results in increased phosphorylation of PTK2B protein] | affects reaction|increases phosphorylation | 16236484
|
C511689 |
(N)-methanocarba-2MeSADP |
IGF1 protein affects the reaction [(N)-methanocarba-2MeSADP results in increased phosphorylation of PTK2B protein] | affects reaction|increases phosphorylation | 16236484
|
C511689 |
(N)-methanocarba-2MeSADP |
(N)-methanocarba-2MeSADP results in increased phosphorylation of PTK2B protein | increases phosphorylation | 16236484
|
C511689 |
(N)-methanocarba-2MeSADP |
PLD2 protein affects the reaction [(N)-methanocarba-2MeSADP results in increased phosphorylation of PTK2B protein] | affects reaction|increases phosphorylation | 16236484
|
D011189 |
Potassium Chloride |
1-Butanol inhibits the reaction [Potassium Chloride results in increased phosphorylation of PTK2B protein] | decreases reaction|increases phosphorylation | 18004999
|
D011189 |
Potassium Chloride |
CAMK2D protein affects the reaction [Potassium Chloride results in increased phosphorylation of PTK2B protein] | affects reaction|increases phosphorylation | 18004999
|
D011189 |
Potassium Chloride |
PLD2 protein promotes the reaction [Potassium Chloride results in increased phosphorylation of PTK2B protein] | increases phosphorylation|increases reaction | 18004999
|
D011189 |
Potassium Chloride |
Potassium Chloride results in increased phosphorylation of PTK2B protein | increases phosphorylation | 18004999
|
C017947 |
sodium arsenite |
sodium arsenite promotes the reaction [Ethanol results in increased phosphorylation of PTK2B protein] | increases phosphorylation|increases reaction | 18182400
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of PTK2B protein | increases expression | 19072884
|
D013629 |
Tamoxifen |
Tamoxifen results in decreased expression of PTK2B mRNA | decreases expression | 15590111
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of PTK2B protein | increases activity|increases phosphorylation | 16877402
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of PTK2B mRNA | increases expression | 16140955
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of PTK2B mRNA | affects cotreatment|increases expression | 17183730
|
D014750 |
Vincristine |
Vincristine results in increased phosphorylation of PTK2B protein | increases phosphorylation | 11478917
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.22 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
7.63 | 17676605 18926900 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
7.63 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.64 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
9.38 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
9.38 | 11192467 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.81 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Vincristine |
4.81 | 19825857 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.56 | 3712494 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.37 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.57 | 16712894 17306315 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.23 | 21441931 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
4.99 | 15451040 15451039 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.36 | 15955085 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.90 | 17688650 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Manganese |
10.06 | 16910769 |
MESH:D000756 |
Anemia, Sideroblastic |
|
manganese chloride |
10.06 | 16910769 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.50 | 15513904 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
8.14 | 11141031 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
8.14 | 17497229 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
6.86 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
6.86 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.19 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.24 | 16456186 |
MESH:D001259 |
Ataxia |
|
1-Butanol |
5.28 | 7820390 |
MESH:D050197 |
Atherosclerosis |
|
7-ketocholesterol |
4.71 | 16632123 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.04 | 18177632 18985861 17507914 19232924 17157402 20603192 18396377 18558336 18775368 19460635 18940202 15238991 17688650 18316065 16609825 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.09 | 16935849 |
MESH:D001528 |
Behcet Syndrome |
|
Colchicine |
5.79 | 15870978 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.69 | 11289319 1440618 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.91 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
3.32 | 16206674 16197459 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.19 | 8888407 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.37 | 14601052 |
MESH:D001919 |
Bradycardia |
|
Carbachol |
5.58 | 12411408 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.53 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Acrylamide |
1.99 | 18183576 16253758 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
1.99 | 16115903 15939500 17369602 16264153 19526202 17426702 17983394 16595493 11325840 16096432 15692762 16322301 15994142 15567936 16826403 15136595 18382427 18695136 15668708 16935488 18234424 18628466 15993339 15634643 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.99 | 20544844 19244106 11161223 19059307 19115204 18855134 19189212 17242785 19288272 16873071 19221464 20859285 15565566 19289846 18815881 16273361 19487384 19103187 19155303 18425577 20135344 18984771 17049068 16202921 17893378 21138602 17261762 18997820 20390343 18821012 18629630 20005174 19011961 19410462 15668708 20065188 19084267 21152245 19189210 17440819 19142967 19200415 19066611 18351453 16818667 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.99 | 16443354 16166294 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.26 | 16813970 |
MESH:D002056 |
Burns |
|
Ethanol |
4.33 | 16374292 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.48 | 16051944 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.19 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.83 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
13.18 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
13.18 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
13.18 | 18059187 17876044 16023760 16234567 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
13.18 | 15289165 15763234 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
13.18 | 17306315 15276417 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
13.18 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
13.18 | 1917145 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
10.06 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
10.06 | 16201981 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Vincristine |
10.06 | 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
13.28 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
13.28 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
13.28 | 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
13.28 | 16096774 16051514 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Vincristine |
13.28 | 6189445 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.33 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
3.26 | 19332462 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.32 | 17928571 17329180 17519947 15505089 17382496 15811867 16952015 18627295 16612575 17131338 17308081 16731534 17974986 15792986 16278810 17351982 16455267 16651473 15476868 16364871 16242529 16269455 17007740 16109756 17924179 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.83 | 17334414 16243910 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
3.29 | 16936243 |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.90 | 17460283 |
MESH:D002418 |
Cattle Diseases |
|
Acrylamide |
5.12 | 12510666 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
9.91 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
9.91 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
9.91 | 19524636 20056578 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.26 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.59 | 20734317 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
2.91 | 19486331 9022650 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.83 | 16461808 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.41 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
5.69 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.69 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.39 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
2.44 | 15824018 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18802399 18259882 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
5.14 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
5.14 | 10194807 19302082 15451040 15451039 15513904 11198716 11873399 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
5.14 | 9224671 9125849 9211117 9664655 17551590 14991402 10589399 8800419 9142499 16925845 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
5.14 | 17688650 16575769 8888407 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
3.70 | 18551238 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.04 | 19031437 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
6.01 | 18759878 11298694 8970840 11906362 14531868 8156756 2524372 12868966 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
6.01 | 12438553 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.19 | 3621924 2952479 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.21 | 19279558 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.40 | 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
10.92 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
10.92 | 18289764 1440618 11289319 6679447 6482804 9328219 9653073 8291058 18648102 16192314 18692083 7440962 9022650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
10.92 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
10.92 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
10.92 | 19641884 1733752 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.43 | 18602426 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.75 | 1851702 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
4.15 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
6.39 | 19703484 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
6.39 | 8273558 8113982 15177302 7812673 11698051 16716910 9599246 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.14 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
3.23 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
11.26 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
11.26 | 19155303 20544844 17893378 16202921 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
11.26 | 16569247 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.83 | 18037988 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
3.84 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.59 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.77 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.32 | 6426943 7562514 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
3.98 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.74 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.33 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
4.33 | 16704527 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.34 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
11.56 | 16409862 19236843 18620774 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
11.56 | 14986274 19224547 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
11.56 | 14986274 19224547 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.33 | 17920746 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.04 | 16709447 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
4.97 | 16946407 15513904 10194807 15451040 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.56 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.82 | 8888407 18558336 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.69 | 6705139 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.20 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
10.35 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
10.35 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
3.20 | 17994277 |
MESH:D005756 |
Gastritis |
|
Ethanol |
4.36 | 15046732 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.35 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
10.79 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Manganese |
10.79 | 17043766 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
10.79 | 17312396 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.74 | 7505956 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
7.12 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.12 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.83 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
2.72 | 9664655 14991402 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.26 | 17875725 18674790 14766674 16707910 16495754 16144979 16244372 17888722 16879835 12587719 18006777 16330681 16244371 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.14 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.61 | 15692506 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.21 | 6705139 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
2.95 | 7520565 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
10.91 | 18501091 15147373 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
10.91 | 12676792 |
MESH:D006689 |
Hodgkin Disease |
|
Vincristine |
10.91 | 17606976 16135485 16794504 15147373 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.54 | 17688650 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
7.16 | 18783367 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.16 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.25 | 16778211 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
10.07 | 15034207 |
MESH:D006965 |
Hyperplasia |
|
halofuginone |
10.07 | 11874485 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
2.81 | 17042910 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.31 | 16612254 |
MESH:D007247 |
Infertility, Female |
|
Acrylamide |
4.91 | 11020651 |
MESH:D007248 |
Infertility, Male |
|
Acrylamide |
6.56 | 15749267 15355880 12507653 11020651 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.56 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
10.62 | 11099482 8960868 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
10.62 | 17296493 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
10.62 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
10.62 | 15177302 7562506 7812673 11698051 8273558 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.45 | 17994277 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.69 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
9.36 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.36 | 17551590 15992940 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
5.65 | 15699352 16775033 15369732 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
5.65 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
9.16 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
9.16 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
10.89 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
10.89 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
10.89 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
4.71 | 16316344 |
MESH:D007859 |
Learning Disorders |
|
Colchicine |
9.26 | 11749816 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
9.26 | 15451040 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.61 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.83 | 16085563 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.41 | 16932348 19285840 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.67 | 17596541 16294345 19850784 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.67 | 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
2.94 | 19642359 17712046 19035177 17294898 17368321 16891316 17217047 19029980 17339181 12679006 17107899 17649720 16140955 19225113 16935935 16823087 17301526 17506722 16331271 17361223 15748426 9834237 16766008 16788101 19075265 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
7.55 | 17676605 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
7.55 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.93 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
6.66 | 15289165 |
MESH:D008103 |
Liver Cirrhosis |
|
halofuginone |
6.66 | 17180598 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.77 | 18295389 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
2.99 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
8.16 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
8.16 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
8.16 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
halofuginone |
8.16 | 12175628 11172339 14739098 18458672 16489207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
8.16 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
8.16 | 18397230 16248980 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.33 | 17207112 17347304 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
6.72 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
6.72 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
6.72 | 16684651 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
8.71 | 6135515 2876784 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
8.71 | 598648 1399818 3712494 6587162 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
8.71 | 17085340 16842330 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.96 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
3.93 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
7.99 | 15824018 11195469 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
7.99 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
7.99 | 19931552 17077188 15276417 17306315 16712894 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
7.99 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
7.99 | 11807781 |
MESH:D008175 |
Lung Neoplasms |
|
Vincristine |
7.99 | 6189445 19825857 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.23 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.53 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.25 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.44 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
8.89 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
8.89 | 19196723 14580682 19196722 11731420 16827153 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
8.89 | 8985016 |
MESH:D020149 |
Manganese Poisoning |
|
Manganese |
11.92 | 19453300 16568477 16551646 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
11.92 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.65 | 17453147 |
MESH:D008545 |
Melanoma |
marker/mechanism |
|
| 19718025 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
6.77 | 16827129 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
6.77 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
6.77 | 19393235 12393984 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
6.77 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
10.79 | 15990972 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Vincristine |
10.79 | 15990972 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
3.88 | 15451040 18411066 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.11 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
2.93 | 17638057 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
2.96 | 18803445 18765137 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.21 | 15792986 |
MESH:D009069 |
Movement Disorders |
|
Manganese |
4.71 | 16551646 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.46 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
3.28 | 15867202 15744524 16118317 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.74 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
11.28 | 9809623 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
11.28 | 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
11.28 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.98 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
Vincristine |
5.98 | 17284715 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.54 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
8.72 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
8.72 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
8.72 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.41 | 19410462 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
4.57 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
4.57 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.35 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.67 | 19196722 19189210 19200415 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.45 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.73 | 15640375 16889571 |
MESH:D009410 |
Nerve Degeneration |
|
Acrylamide |
8.33 | 12387366 11264303 12387367 |
MESH:D009410 |
Nerve Degeneration |
|
Manganese |
8.33 | 16551646 |
MESH:D009422 |
Nervous System Diseases |
|
Acrylamide |
4.71 | 12507653 12164553 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
3.47 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
15.58 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
15.58 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
15.58 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
15.58 | 16359493 8888407 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.09 | 15555623 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Vincristine |
5.38 | 12837982 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
7.95 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
7.95 | 6482804 4026338 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.69 | 3988306 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
3.58 | 17882678 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.86 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
4.52 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
4.52 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.65 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
8.05 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
8.05 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
8.05 | 15976015 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
13.79 | 7296757 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
13.79 | 12065085 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
13.79 | 12065085 8330346 18922899 18404319 |
MESH:D010300 |
Parkinson Disease |
|
Manganese |
3.25 | 11181820 |
MESH:D020734 |
Parkinsonian Disorders |
|
Manganese |
4.19 | 16140633 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Acrylamide |
4.80 | 11510240 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.14 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.83 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.83 | 17638057 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
7.50 | 21297632 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Vincristine |
7.50 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
3.51 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.71 | 16888761 16868541 16729912 15749863 18437689 15897917 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.71 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.71 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.31 | 16636307 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.21 | 12752131 11422049 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.47 | 16723453 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
3.90 | 17922066 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
3.72 | 11700416 18379247 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.14 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
9.86 | 16116481 16283617 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
9.86 | 19155313 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.71 | 16767912 17710206 17203757 18313854 15625365 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
3.93 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.46 | 17846226 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.03 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
8.62 | 18551238 |
MESH:D012640 |
Seizures |
|
Ethanol |
8.62 | 9754883 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
8.62 | 14763951 11738929 11044598 15475178 1511512 17978042 16876388 3137016 |
MESH:D012871 |
Skin Diseases |
|
halofuginone |
3.43 | 11874485 |
MESH:D012878 |
Skin Neoplasms |
marker/mechanism |
|
| 19718025 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
16.28 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
16.28 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
16.28 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
16.28 | 11807781 8985016 12065085 18404319 8330346 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
16.28 | 16467112 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.25 | 17203757 15625365 16767912 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
3.96 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.71 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
8.72 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
8.72 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.21 | 12833885 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
4.00 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
2.53 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.53 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
6.60 | 15138204 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
6.60 | 11906479 16755016 17918041 17189318 9211565 9562338 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
3.97 | 9754883 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Vincristine |
5.55 | 12837982 |
MESH:D013733 |
Testicular Diseases |
|
Acrylamide |
4.90 | 15864552 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
15.18 | 6582329 1399818 3712494 6587162 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine |
15.18 | 16940797 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
15.18 | 16010429 17909728 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
15.18 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.51 | 16051514 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.90 | 17262798 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.03 | 16040207 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.19 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
14.38 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
14.38 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
14.38 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
14.38 | 16712894 11723127 17306315 16452187 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
14.38 | 17572228 8653321 16712894 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.32 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
3.99 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
8.48 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
8.48 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.28 | 16752155 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
4.49 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.10 | 17056641 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
3.90 | 16364871 17678736 17638931 17334414 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.75 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.69 | 16287080 |
MESH:D014947 |
Wounds and Injuries |
|
lysophosphatidic acid |
5.04 | 15541073 |